To reach the WHO target of hepatitis C virus (HCV) elimination by 2025, Taiwan started to
implement free-of-charge direct-acting antiviral (DAA) treatment programme in 2017 …

Background Microelimination of hepatitis C virus (HCV) among people living with human
immunodeficiency virus (HIV) may be feasible in Australia, given unrestricted access to …

Background Gay and bisexual men (GBM) are a key population affected by human
immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection. We aimed to measure …

Hepatitis C virus (HCV) infection remains a major health problem for people living with
human immunodeficiency virus (HIV). It is estimated that 2.3 million people are living with …

The estimated prevalence of anti-HCV was 3.1% in Taiwan. Studies have shown iatrogenic
behavior was the major transmission route. It is highest in specific populations including …

Abstract Introduction The World Health Organization targets for hepatitis C virus (HCV)
elimination include a 90% reduction in new infections by 2030. Our objective is to review the …

Background Bolstered by the high efficacy of hepatitis C virus (HCV) treatment, the World
Health Organization has called for HCV elimination by 2030. People with HIV (PWH) have …

Background Data on hepatitis C virus (HCV) reinfection in East Asian people with HIV after
treatment-induced sustained virologic response (SVR) are limited. Methods HIV/HCV …

BACKGROUND Little is known about the engagement in hepatitis C virus (HCV) care and
completion of HCV treatment in people living with human immunodeficiency virus …

Background The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA)
led to a dramatic decrease in hepatitis C virus (HCV) prevalence. Human immunodeficiency …